|
3.1 Prévention - Tabac
|
|
|
|
3.8 Prévention - Alimentation
|
|
|
Adherence to Healthy Diets Associated with Lower Cancer Risk [AACR]
|
|
|
|
|
|
In
order to examine links between the four nutritional indices and cancer
risk, Srour, Touvier, and colleagues drew data from the NutriNet-Santé
study, launched in 2009 to investigate associations between nutrition
and health in a French cohort. This study included a large sample of
41,543 participants aged 40 or older, who had never been diagnosed with
cancer prior to inclusion in the study.
|
|
|
|
|
|
|
4.14 Dép., diag. & prono. - Thyroïde
|
|
|
|
5.1 Traitements - Pré-clinique
|
|
|
|
5.12.5 Immunothérapies - Pharma
|
|
|
|
5.12.6 Immunothérapies - AMM
|
|
|
|
FDA Alters Approved Use of Two Checkpoint Inhibitors for Bladder Cancer [NCI]
|
|
|
|
|
|
Under
the change, pembrolizumab and atezolizumab should be used as an
initial, or first-line, treatment in only those people with metastatic
bladder cancer who can’t receive cisplatin-based chemotherapy and whose
tumors have high levels of PD-L1. The assessment of PD-L1 levels must be
made using an FDA-cleared test.
|
|
|
|
|
|
|
5.12.8 Immunothérapies - Economie
|
|
|
|
|
5.2 Pharma
|
|
|
AstraZeneca Can't Boost a Cancer Drug Stockpile for Brexit [Bloomberg]
|
|
|
|
|
|
The
drugmaker is already making Zoladex, a drug for cancers of the prostate
and breast, at full capacity, Chief Executive Officer Pascal Soriot
said in an interview. That means inventory can’t be increased to four
months from three, as the company is doing with other products in case
of Brexit-related distribution delays.
|
|
|
|
|
|
|
5.2.1 Pharma - Partenariats
|
|
|
|
5.2.3 Pharma - économie
|
|
|
|
Sutro Biopharma Announces $85.4 Million Series E Round [Sutro]
|
|
|
|
|
|
STRO-001
and STRO-002 were developed using Sutro’s proprietary cell-free protein
synthesis and site-specific conjugation platforms, which facilitate
precision design and rapid empirical optimization of protein conjugates
to treat cancer and other diseases.
|
|
|
|
|
|
|
|
5.4 Traitements - Economie
|
|
|
|
6.1 Observation
|
|
|
|
6.6 Publications
|
|
|
|
|
6.7 DMP, Big Data & applis
|
|
|